Elsevier
Scientific publishing and research intelligence platform for institutions and professionals.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Elsevier BV
- Entity type
- COMPANY
- Founded
- 1880
- Headquarters
- Netherlands
- Company size
- >5,000
- Market role
- Publisher & Media Owner
- Official website
- elsevier.com
What Elsevier does
Elsevier combines proprietary content ownership with software and analytics distribution. It creates and licenses high-value scientific and medical content, then layers discovery, benchmarking, workflow and decision-support tools on top of that corpus. Revenue is driven mainly by recurring institutional agreements, with additional monetisation from author-side publishing charges, transactional access, education products and specialised media inventory tied to its journals.
Category differentiation
Elsevier is a scientific publishing and research information company, not a general consumer media publisher or a standalone foundational AI model provider. It competes more directly with academic information groups such as Clarivate, Springer Nature and Wiley than with mainstream news publishers.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Elsevier is a Netherlands-headquartered scientific publishing and research information business within RELX Group plc. It sells access to proprietary journals, databases, analytics tools, clinical decision support products, education platforms and research workflow software. Its portfolio includes ScienceDirect for full-text scientific content, Scopus and SciVal for research analytics, Mendeley for reference management, and specialist products for clinical, chemistry and biomedical use cases. The business primarily monetises through institutional subscriptions, platform licensing and other recurring contracts with universities, libraries, hospitals, governments, pharmaceutical companies and corporate R&D teams. It also earns from open access publishing fees, pay-per-view content, education software, and smaller media-related revenue streams such as advertising, reprints and sponsored supplements across owned journal properties.
Company news briefing
Briefing updated:
Building on its legal actions against unauthorised AI training and the expansion of LeapSpace™, Elsevier has launched Nora AI, an AI-powered learning support tool for healthcare students and educators. Additionally, the company has updated its generative AI policies for journals to support responsible use while protecting trust. These initiatives, alongside its ongoing partnership with NHS 24, demonstrate Elsevier's dual strategy of defending its intellectual property against platforms like Google while actively integrating trusted, evidence-based AI solutions across the research and healthcare sectors.
Business model & monetisation
Elsevier uses a hybrid recurring-revenue model led by subscription and licensing fees for content databases, analytics platforms and workflow software. It also charges article processing charges for open-access publishing, pay-per-view and content purchases for individual access, institutional SaaS subscriptions for education and clinical tools, and media-related fees for advertising, reprints and sponsored supplements.
- Institutional content subscriptions and licences
- Content Subscription
- Research analytics and workflow software subscriptions
- Software Subscription
- Open access publishing fees
- Service Fee
- Pay-per-view articles, eBooks and individual product purchases
- One-time Sale
- Advertising, reprints and supplements
- Service Fee
Products & capabilities
No products with linked sources are available in this view.
Products & market categories
Competitors & alternatives
- Holtzbrinck
Diversified publishing group spanning research, education, books, and news media.
- Wiley
Scholarly publishing, education software, and knowledge licensing company.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Updated generative AI policies for journals: supporting responsible use while protecting trust
Recorded impact score: 4/5
Elsevier updates generative AI policies for journals to support responsible use while protecting trust.
How NHS 24 and Elsevier are turning uncertainty into confident, clinically safe decisions
Recorded impact score: 3/5
The featured story on the Elsevier About page has been updated from 'The future we build could depend on research we don’t read' to a new case study about NHS 24, highlighting a partnership to improve clinical decision-making.
Careers & open positions
Open positions indexed from verified career portals and applicant tracking systems.
| Position | Department | Location | Posted |
|---|---|---|---|
| Principal Data Scientist I(Lead) | Data, AI & Analytics | 2 Locations | |
| Customer Success Implementation Analyst(Mid-Level) | Customer Success & Client Operations | 3 Locations | |
| Nursing Education Program Implementation Specialist(Mid-Level) | Customer Success & Client Operations | 6 Locations | |
| Digital Customer Success Manager, Global(Mid-Level) | Customer Success & Client Operations | 2 Locations | |
| 0926-IND-185 - Lead Data Analyst(Lead) | Data, AI & Analytics | 2 Locations |
Explore company relationships
Questions about Elsevier
What is Elsevier?
Elsevier is a scientific publishing, research information and workflow software business within RELX, serving academic, clinical and R&D markets.
Who uses Elsevier?
Universities, libraries, researchers, hospitals, government agencies, pharmaceutical companies, educators and corporate R&D teams use its platforms and content.
How does Elsevier make money?
It mainly earns from institutional subscriptions and licences, plus open-access publishing fees, transactional content sales, software subscriptions and smaller media-related revenues.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
18 publicly documented primary sources and citations linked across the market graph.
Continue your research on Elsevier
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.